Sox Therapeutics AB
559526-5900ActiveDeveloping targeted AAV gene therapies for malignant brain tumors.
Biotechnology Companysoxtherapeutics.se
Yleiskatsaus
- 1–4
- Työntekijät
- Tuntematon
- Liikevaihto
- 2025
- Perustettu
Avainpäättäjät
christina herder
Board Member, Business Advisor
Mateo Santurio
Board Member, Business Advisor
FREDRIK Swartling
Chief Executive Officer, Founder, Board Member
Annika ericsson
AAV Gene Therapy Expert, CMC Drug Development
+4 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Sox Therapeutics is an emerging biotechnology company founded in 2025 with the primary mission of improving cancer treatment outcomes. They specialize in developing highly innovative, targeted gene therapies specifically designed for patients suffering from malignant brain tumors. Their core technol...
Valo Therapeutics Oy